Employer record · Brookline, MA · FY2023–FY2025

Chroma Medicine, Inc.

    Certified LCAs
    4
    FY2024–FY2026
    USCIS approvals
    4
    3 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $135k
    certified LCAs

    Jobs not indexed yet

    Does Chroma Medicine, Inc. sponsor H-1B visas?

    Yes — by its record, Chroma Medicine, Inc. is a small-scale H-1B sponsor: it filed 4 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 4 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided Apr 23, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 5 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Chroma Medicine, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2310–
    FY2433100%
    FY2511100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Molecular and Cellular Biologists 19-10294$135k

    Most-filed job titles

    1. Associate Director, Preclinical Pharmacology1$190k
    2. Associate Scientist I, Delivery Sciences1$116k
    3. Scientist I, Directed Evolution [00051489]1$128k
    4. Scientist II, Payload Sciences1$142k

    LCAs per title and median wage offered.

    Where the jobs were

    1. Massachusetts4 LCAs

    We haven't indexed Chroma Medicine's jobs yet

    We read jobs straight from employers' own career sites and haven't added Chroma Medicine's yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • CHROMA MEDICINE INC (USCIS)
    • Chroma Medicine, Inc. (LCA)
    • NCHROMA BIO INC (USCIS)
    • nChroma Bio, Inc. (LCA)

    Chroma Medicine, Inc. H-1B: questions people ask

    Does Chroma Medicine, Inc. sponsor H-1B visas?

    Yes — by its record, Chroma Medicine, Inc. is a small-scale H-1B sponsor: it filed 4 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 4 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided Apr 23, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Chroma Medicine, Inc. still sponsoring H-1B in 2026?

    Chroma Medicine, Inc. had 0 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 1 in FY2025. The latest one in our data was decided Apr 23, 2025. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Chroma Medicine, Inc. get approved?

    USCIS recorded 4 approvals (3 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Chroma Medicine, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Chroma Medicine, Inc.?

    The median wage offered on Chroma Medicine, Inc.'s certified LCAs in FY2024–FY2026 was $135k a year. By job title: Associate Director, Preclinical Pharmacology $190k (1 LCAs), Associate Scientist I, Delivery Sciences $116k (1 LCAs) and Scientist I, Directed Evolution [00051489] $128k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Chroma Medicine, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Molecular and Cellular Biologists (4).

    Where are Chroma Medicine, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): Massachusetts (4).

    Is Chroma Medicine, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Chroma Medicine, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Chroma Medicine's yet.